Molecular Formula : C45H55N9O6
Molecular Weight :817.9
CAS No. : 158861-67-7
For RESEARCH PURPOSES ONLY
The GHRP-2 graphs are from Synergistic Release of Growth Hormone by GHRP and GHRH: Scope and implication by Cyril Y. Bowers in Growth Hormone Secretagogues in Clinical Practice, CRC; 1st edition (May 15, 1998)
The last three come from a study that indicated that GHRP-2 was equally powerful to Hexarelin. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH, E Arvat, L di Vito, B Maccagno, F Broglio, MF Boghen, R Deghenghi, F Camanni, and E Ghigo, Peptides, Jan 1997; 18(6): 885-91
The above graphs indicate that a little GHRP-2 is very powerful, Although not very effective on its own when combined with 100mcg of GHRH it is very synergistic.
The above graphs indicate that you can use very large doses of GHRP-2 and get a greater GH release. The 10mcg/kg was two to three times more effective then 1mcg/kg.
In fact in this study the 10mcg/kg dose of GHRP-2 was about equal to the synergistic release of 1mcg/kg of GHRP-2 & 1mcg/kg of GHRH.
The above graph indicates the young are capable of greater responses then the old.
The above graph indicates that GHRP-2 is equipotent to Hexarelin in effecting GH release.
The above graph indicates that the young respond better then the old BUT that the old respond better to GHRP-2 then to Hexarelin.
The above table demonstrates a similar (slightly better) GH release profile between both GHRP-2 and Hexarelin in young and old w/o regard for gender.
The study from which GH equivalence was demonstrated found that there can be cortisol and prolactin release within the normal range from both GHRP-2 and Hexarelin.
In conclusion, GHRP-2 and Hexarelin have similar, strong, dose- and age-related GH-releasing effect in humans. ” – Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH, E Arvat, L di Vito, B Maccagno, F Broglio, MF Boghen, R Deghenghi, F Camanni, and E Ghigo, Peptides, Jan 1997; 18(6): 885-91
There is room for Ipamorelin in our world. For those super-sensitive and for those that want to mix half GHRP-2 & Ipamorelin achieve a unique GH release profile.
THIS PRODUCT IS NOT FOR HUMAN USE NOR IS IT INTENDED TO
TREAT PREVENT OR CURE ANY DISEASES. canadapeptides WILL
DENY ANY ORDER IF WE FEEL IT WILL NOT BE USED TO THE
CONDITIONS SPECIFIED IN OUR DISCLAIMER WHICH IS AGREED
UPON BEFORE ENTERING THE SITE.